Risedronate and jaundice Patient Reports February 12, 2012

Risedronate Side Effects Report #5890688-0
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 73 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, decreased appetite, gastritis erosive, jaundice , liver disorder. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, ASPARA, ZOLPIDEM TARTRATE, ETODOLAC, METHYCOBAL, SOLON, CRESTOR, EPADEL. Patient recovered.

Risedronate Side Effects Report #4621086-5
Risedronate side effect was reported by a Physician from on Mar 14, 2005. Female patient, 64 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with VITAMIN D3, URSODIOL, MEVALOTIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5266652-1
Risedronate side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 57 years of age, was diagnosed with osteoporosis , back pain  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: hepatic failure, hepatitis fulminant, jaundice , malaise. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ONEALFA, BRUFEN. Patient died.

Risedronate Side Effects Report #5252864-X
Risedronate side effect was reported by a Physician from JAPAN on Feb 14, 2007. Female patient was treated with Risedronate. After drug was administered, patient experienced the following side effects: hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ONEALFA, IBRUPROFEN. Patient recovered.